The Deadly Deception: Unmasking the Global Threat of Contaminated Cough Syrups

Eli Lilly Unveils $1 Billion India Investment to Supercharge Mounjaro Production

Telangana's Trillion-Dollar Leap: Eli Lilly Injects $1 Billion, Reshaping India's Pharma Future

India's Imperative: Seizing the AI Revolution in Drug Discovery

US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm

Trump's Bold Pharma Tariff Move: Will India Feel the Pinch?

A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis

Trump's Tariff Twist: Generics Spared, But India's Export Horizon Remains Cloudy

Trump's Rx for Disaster: Why a Paracetamol Ban Is a Perilous Prescription

Unlocking India's Pharmaceutical Potential: A Strategic Blueprint for Self-Reliance and Innovation

Shukra Pharma Forges Landmark Pan-India Distribution Alliance with Wockhardt, Eyes Massive Market Expansion

Sun Pharma's Strategic Brilliance: A Diversified Empire Defying Regulatory Storms

Glenmark Pharma's Q1 Fizzles: Shares Dip as Earnings Fail to Ignite Investor Confidence